Zenflow Spring System: 3-Year Data Shows Durability of Clinical Benefits for BPH Patients
Zenflow, Inc. released three-year data from its ZEST pilot studies, demonstrating sustained positive outcomes for patients using the Zenflow...
Zenflow, Inc. released three-year data from its ZEST pilot studies, demonstrating sustained positive outcomes for patients using the Zenflow...
Janssen-Cilag International NV announced promising interim results from the Phase 2b SunRISe-1 study (Cohort 4) of TAR-200, a gemcitabine-releasing...
Stablepharma Ltd. has initiated a Phase 1 clinical trial for its lead candidate, SPVX02, a fridge-free tetanus and diphtheria...
Foghorn Therapeutics announced preclinical data for several potential first-in-class cancer medicines, including FHD-909, a SMARCA2 inhibitor, and its selective...
Tenaya Therapeutics announced interim data from its RIDGE natural history study of adults with arrhythmogenic right ventricular cardiomyopathy (ARVC)...
Inmagene Biopharmaceuticals announced positive topline results from a Phase 2a trial of IMG-007, a non-depleting anti-OX40 monoclonal antibody, in...
Northstrive Biosciences, a subsidiary of PMGC Holdings, received positive feedback from the FDA regarding its pre-IND meeting request for...
SpyGlass Pharma announced positive 18-month data from its first-in-human study of a novel drug delivery platform for glaucoma and...
Bioxodes SA announced positive interim results from its Phase 2a BIRCH trial of BIOX-101 for intracerebral hemorrhagic stroke (ICH)....
Distalmotion, a MedTech company specializing in robotic surgery, has completed clinical trials for cholecystectomy and benign hysterectomy in the...